与癌症相关的PKM2突变对酶活性和体调节的影响:对代谢重编程的结构和功能洞察
Saurabh Upadhyay1, Mohit Bhardwaj1, Sivakumar Prasanth Kumar2
1Kusuma School of Biological Sciences, Indian Institute of Technology, New Delhi 110016, India.
Biochemistry
|March 13, 2025
概括
酸盐激酶M2 (PKM2) 的与癌症相关的突变破坏了它的功能和调节. 这些PKM2变化影响糖解,并可能导致瘤中的代谢重编程.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 哺乳动物酸盐激酶M2 (PKM2) 对于糖解至关重要,在瘤中过度表达.
- 已知与癌症相关的PKM2突变,但它们的功能影响尚不清楚.
研究的目的:
- 研究与癌症相关的PKM2突变的结构和功能后果.
- 了解这些突变如何影响酶动力学,全调节和寡合化.
主要方法:
- 计算建模计算建模
- 在X射线晶体学.
- 生物化学测定 生物化学测定
- 四个特定的PKM2突变 (P403A,C474S,R516C,L144P) 的表征
主要成果:
- 突变破坏了全体信号传递,改变了调节部和活性部之间的通信.
- X射线结晶学揭示了形状变化,有利于C474S和R516C突变的不太活跃的二维状态.
- 突变者显示最大速度降低,基质亲和力较低,果糖-1,6-双酸盐 (FBP) 激活受损.
- 性pH条件 (瘤微环境) 进一步破坏了PKM2的寡合状态的稳定.
结论:
- PKM2对与癌症相关的突变高度敏感.
- 这些变化损害了PKM2的酶调节,可能导致癌细胞代谢重编程.
- 了解这些突变可以了解癌症代谢和治疗策略.
相关概念视频
Allosteric Regulation
57.4K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Allosteric Proteins-ATCase
5.6K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.6K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K


